OKYO Pharma Bullish Thesis
OKYO Pharma's presentation highlights their key drug candidate, OK-101, developed to treat Dry Eye Disease (DED) and Neuropathic Corneal Pain (NCP).
Okyo Pharma Ltd (OKYO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,652,768 | $5,479,152 | +1% | 0.02% |
| 2. | Stonepine Capital Timothy P. Lynch | 862,996 | $1,294,494 | +2% | 0.73% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 580,596 | $870,894 | -1% | 0% |
| 4. | Opaleye Management James A. Silverman | 375,204 | $562,806 | 0.05% | |
| 5. | Quantinno Capital Hoon Kim | 33,255 | $49,882 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.48 | 5,000 | $7,385.00 | 35,201 | 2026-07-21 | Filing | |
| $1.54 | 15,000 | $23,085.00 | 15,000 | 2026-07-22 | Filing | |
| $1.40 | 3,500 | $4,900.00 | 112,420 | 2026-07-21 | Filing | |
| $1.45 | 22,500 | $32,625.00 | 10,873,916 | 2026-07-21 | Filing | |
| $1.40 | 25,000 | $35,000.00 | 10,851,416 | 2026-07-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 809,317 | $1,213,976 | 0.02% | |
| 2. | 55,009 | $82,514 | 0% | |
| 3. | 37,769 | $56,654 | 0% | |
| 4. | 33,255 | $49,883 | 0% | |
| 5. | 12,812 | $19,218 | 0% |
News See All
Hedge Fund Resource Center